Zynerba Pharmaceuticals Inc. (ZYNE) tumbled -6.69% or -0.41 to $5.72. It is near 2.21 million shares traded, which is 239.45% compare to the average total volume 924592. The market cap of ZYNE is $100.83 million. The year to date change is 58.1%. The 52 week price range is from $2.75 to $12.5. Price of ZYNE have changed 27.44% during last week. It have changed 53.25% over last month, 4.07% over last 3 months, 0.00% over last 6 months and -43.08% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 4.27. It is -25.35% below current price. The 200-day Moving Averages for ZYNE is 7.36. It is 28.67% above current price. The 52-week High is 12.5. It is 118.53% from the current price. The 52-week Low is 2.75. It is -51.92% from current price.
There are some statistics of ZYNE. It is has market cap $100.83 million. The share outstanding is 17.63 million. The average volume is 924592. The percent of top 15 Institution holding is 24.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -62.99%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -55.40%.